Yayınlar & Eserler

Yayın Ağı
Makaleler 7
Tümü (7)
SCI-E, SSCI, AHCI (7)
SCI-E, SSCI, AHCI, ESCI (7)
Scopus (5)
TRDizin (1)

1. Cytogenetic profile of adult AML patients in Turkey: a single center study with comprehensive comparison with literature

ÇIRAKOĞLU A., KURU R. D., YILMAZ Ş., DEVİREN A., ÖNGÖREN Ş., Yalniz F. F., et al.
AFRICAN HEALTH SCIENCES , cilt.22, sa.3, ss.183-191, 2022 (SCI-Expanded) Creative Commons License identifier identifier

2. Evaluation of the physical and emotional effects of the COVID-19 pandemic on patients with fibromyalgia and chronic low back pain: A multicenter cross-sectional controlled study

Bagcier F., Kibar S., Evcik D., Ketenci A., Sindel D., SONEL TUR B., et al.
TURKISH JOURNAL OF PHYSICAL MEDICINE AND REHABILITATION , 2022 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier

3. Best Practice Recommendations for Stroke Patients with Dysphagia: A Delphi-Based Consensus Study of Experts in Turkey-Part I: Management, Diagnosis, and Follow-up

Umay E., Eyigör S., Ertekin C., Ünlü Z., Selcuk B., Bahat G., et al.
DYSPHAGIA , cilt.37, sa.2, ss.217-236, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

4. Efficacy and Safety of Imatinib Treatment in Elderly Patients With Chronic Myeloid Leukemia: Real-Life Data and a Single-Center Experience

EŞKAZAN A. E., Ozmen D., ÖZTAŞ M., Bektas F., Bayraktar E. A., Sadri S., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , cilt.21, sa.8, ss.549-557, 2021 (SCI-Expanded) identifier identifier identifier

5. The prognostic value of serum levels of a proliferation-inducing ligand (APRIL) in treatment-naive patients with chronic lymphocytic leukemia

Esatoglu S. N., Keskin D., EŞKAZAN A. E., ELVERDİ T., SALİHOĞLU A., AR M. C., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.51, sa.1, ss.348-354, 2021 (SCI-Expanded) identifier identifier identifier identifier

6. Radotinib and its clinical potential in chronic-phase chronic myeloid leukemia patients: an update.

Eskazan A. E., Keskin D.
Therapeutic advances in hematology , cilt.8, ss.237-243, 2017 (SCI-Expanded) identifier identifier

7. Dasatinib for the treatment of chronic myeloid leukemia: patient selection and special considerations.

Keskin D., Sadri S., Eskazan A. E.
Drug design, development and therapy , cilt.10, ss.3355-3361, 2016 (SCI-Expanded) identifier identifier identifier
Metrikler

Yayın

7

Yayın (WoS)

7

Yayın (Scopus)

5

Atıf (WoS)

37

H-İndeks (WoS)

3

Atıf (Scopus)

31

H-İndeks (Scopus)

2

Açık Erişim

1
BM Sürdürülebilir Kalkınma Amaçları